Published in Annu Rev Med on January 01, 2006
Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol (2012) 2.37
Longitudinal association between prostatitis and development of benign prostatic hyperplasia. Urology (2008) 0.97
A pilot study on acupuncture for lower urinary tract symptoms related to chronic prostatitis/chronic pelvic pain. Chin Med (2007) 0.95
Chemokines and BPH/LUTS. Differentiation (2011) 0.93
Physical activity and chronic prostatitis/chronic pelvic pain syndrome. Med Sci Sports Exerc (2015) 0.90
Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk. Br J Cancer (2013) 0.90
Targeted overexpression of vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer. Cancer Res (2008) 0.88
The Role of the Immune Response in Chlamydia trachomatis Infection of the Male Genital Tract: A Double-Edged Sword. Front Immunol (2014) 0.85
Influence of infection on the distribution patterns of NIH-Chronic Prostatitis Symptom Index scores in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Exp Ther Med (2013) 0.84
Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study. Prostate (2011) 0.82
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med (2014) 0.82
Characterization of autoimmune inflammation induced prostate stem cell expansion. Prostate (2015) 0.81
A novel murine model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a spermine binding protein (p25) peptide. Am J Physiol Regul Integr Comp Physiol (2013) 0.81
Transperineal Sonography Evaluation of Muscles and Vascularity in the Male Pelvic Floor. J Diagn Med Sonogr (2013) 0.80
Reliability of superficial male pelvic floor structural measurements using linear-array transperineal sonography. Ultrasound Med Biol (2014) 0.76
Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Can Urol Assoc J (2014) 0.76
The effect of chronic bacterial prostatitis on semen quality in adult men: a meta-analysis of case-control studies. Sci Rep (2014) 0.75
Survey of a pelvic health physiotherapy community of practice: a pilot study to gain member input to help sustain and advance the group. Physiother Can (2015) 0.75
Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats. BMC Complement Altern Med (2017) 0.75
Proteinase-activated receptor-1 and immunomodulatory effects of a PAR1-activating peptide in a mouse model of prostatitis. Mediators Inflamm (2013) 0.75
Self Management Activation Randomised Trial for Prostatitis (SMART-P): study protocol for a randomised controlled trial. Trials (2011) 0.75
New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals. Oncotarget (2016) 0.75
High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients. Int J Clin Exp Med (2015) 0.75
Chronic bacterial prostatitis in men with spinal cord injury. World J Urol (2014) 0.75
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol (2008) 4.90
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
CLINICAL PRACTICE. Urinary Tract Infections in Older Men. N Engl J Med (2016) 2.76
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci U S A (2009) 2.33
Delayed primary closure of bladder exstrophy: immediate postoperative management leading to successful outcomes. Urology (2011) 2.26
Brain functional and anatomical changes in chronic prostatitis/chronic pelvic pain syndrome. J Urol (2011) 2.08
Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun (2010) 1.72
How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome? J Urol (2006) 1.68
Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol (2003) 1.66
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med (2010) 1.55
Th1-Th17 cells contribute to the development of uropathogenic Escherichia coli-induced chronic pelvic pain. PLoS One (2013) 1.53
Bacteria-induced uroplakin signaling mediates bladder response to infection. PLoS Pathog (2009) 1.53
Molecular effects of genistein on male urethral development. J Urol (2011) 1.51
The MAPP research network: a novel study of urologic chronic pelvic pain syndromes. BMC Urol (2014) 1.47
Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators. J Urol (2010) 1.46
A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression. J Pathol (2015) 1.45
Data mining derived treatment algorithms from the electronic medical record improve theoretical empirical therapy for outpatient urinary tract infections. J Urol (2011) 1.44
Host-pathogen interactions mediating pain of urinary tract infection. J Infect Dis (2010) 1.44
Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome. J Urol (2008) 1.39
Urinary tract infections in women. Med Clin North Am (2011) 1.34
Antigen-specific responses accelerate bacterial clearance in the bladder. J Immunol (2006) 1.32
Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect Immun (2007) 1.29
Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol (2008) 1.28
Asymptomatic bacteriuria and symptomatic urinary tract infections during pregnancy. Urol Clin North Am (2007) 1.24
Urothelial cultures support intracellular bacterial community formation by uropathogenic Escherichia coli. Infect Immun (2009) 1.24
Catastrophizing and pain-contingent rest predict patient adjustment in men with chronic prostatitis/chronic pelvic pain syndrome. J Pain (2006) 1.22
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome. Urology (2002) 1.21
Prostate-specific antigen test in diagnostic evaluation of chronic prostatitis/chronic pelvic pain syndrome. Urology (2006) 1.20
Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder. Infect Immun (2008) 1.17
Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsy. J Urol (2013) 1.17
Uropathogenic Escherichia coli induces extrinsic and intrinsic cascades to initiate urothelial apoptosis. Infect Immun (2006) 1.15
Angiosarcoma of bladder: long-term survival after multimodal therapy. Urology (2007) 1.12
Psychosocial variables affect the quality of life of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome. BJU Int (2007) 1.10
Role of mast cells in male chronic pelvic pain. J Urol (2012) 1.07
Mast cell activation triggers a urothelial inflammatory response mediated by tumor necrosis factor-alpha. J Urol (2002) 1.06
Effect of prostate weight on operative and postoperative outcomes of robotic-assisted laparoscopic prostatectomy. Urology (2007) 1.06
Epithelial differentiation promotes the adherence of type 1-piliated Escherichia coli to human vaginal cells. J Infect Dis (2002) 1.06
CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol (2012) 0.96
A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis (2009) 0.96
Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol (2004) 0.95
Immunoactive prophylaxis of recurrent urinary tract infections: a meta-analysis. Int J Antimicrob Agents (2008) 0.95
Pharmacologic attenuation of pelvic pain in a murine model of interstitial cystitis. BMC Urol (2009) 0.93
Pentosan polysulfate sodium therapy for men with chronic pelvic pain syndrome: a multicenter, randomized, placebo controlled study. J Urol (2005) 0.93
Managing complicated urinary tract infections: the urologic view. Infect Dis Clin North Am (2003) 0.92
Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect (2008) 0.90
O-antigen modulates infection-induced pain states. PLoS One (2012) 0.89
Acute and chronic prostatitis. Med Clin North Am (2004) 0.86
Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Urol Rep (2008) 0.84
Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis (2015) 0.84
Role of bacteria in chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep (2005) 0.84
The expanding role of fluoroquinolones. Dis Mon (2003) 0.83
Epidemiologic insights into pediatric kidney stone disease. Urol Res (2010) 0.82
Chronic bacterial prostatitis and chronic pelvic pain syndrome. BMJ Clin Evid (2015) 0.81
Is it time to change the training of urology residents in the United States? J Urol (2005) 0.81
Long-term results of the bulbourethral sling procedure. J Urol (2005) 0.80
Evaluation of the cytokines in genital secretions of patients with chronic prostatitis. J Urol (2005) 0.79
The role of cytokines in prostatitis. World J Urol (2003) 0.79
Durability of flexible cystoscopes in the outpatient setting. Urology (2013) 0.79
Genitourinary pain syndromes, prostatitis, and lower urinary tract symptoms. Urol Clin North Am (2009) 0.79
Significant clinical practice cost savings through downsizing office supply inventory and just in time ordering. J Urol (2006) 0.78
Urinary tract infections in adults. ScientificWorldJournal (2004) 0.78
The impact of collateral damage on urological care. J Urol (2012) 0.77
Global molecular epidemiology of the O15:K52:H1 extraintestinal pathogenic Escherichia coli clonal group: evidence of distribution beyond Europe. J Urol (2003) 0.77
Management of bacterial urinary tract infections in adult patients with diabetes mellitus. J Urol (2003) 0.77
Cytologic evaluation of urine is important in evaluation of chronic prostatitis. J Urol (2003) 0.75
Evaluation of the DipStreak, a new device with an original streaking mechanism for detection, counting, and presumptive identification of urinary tract pathogens. J Urol (2003) 0.75
Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. J Urol (2003) 0.75
Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. J Urol (2003) 0.75
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound-guided prostate biopsy. BJU Int (2013) 0.75
The economic impact of chronic prostatitis. J Urol (2005) 0.75
Levofloxacin: an updated review of its use in the treatment of bacterial infections. J Urol (2003) 0.75
Molecular epidemiology of 3 putative virulence genes for Escherichia coli urinary tract infection--usp, iha, and iroN(E. coli). J Urol (2003) 0.75
Renal imaging in pyelonephritis. J Urol (2005) 0.75
Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Urol (2005) 0.75
Antibiotic treatment for five days is effective in children with acute cystitis. J Urol (2003) 0.75
Utility of blood cultures in febrile children with UTI. J Urol (2003) 0.75
The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. J Urol (2003) 0.75
Prostatectomy incontinence. J Urol (2002) 0.75
Cranberries for preventing urinary tract infections. J Urol (2005) 0.75
Editorial: Emerging concepts in the management of prostatitis/chronic pelvic pain syndrome. J Urol (2003) 0.75
Urinary tract infection as a possible marker for teenage sex. J Urol (2003) 0.75
Nosocomially acquired urinary tract infections in urology departments. Why an international prevalence study is needed in urology. J Urol (2005) 0.75
Asymptomatic bacteriuria in elderly humans is associated with increased levels of circulating TNF receptors and elevated number in neutrophils. J Urol (2003) 0.75
Cranberry juice and urinary tract infection. J Urol (2005) 0.75
Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in control subjects. J Urol (2003) 0.75
Transurethral needle ablation for the treatment of chronic pelvis pain syndrome (category III prostatitis): a randomized, sham-controlled study. J Urol (2003) 0.75
Types of urethral catheters for management of short-term voiding problems in hospitalised adults. J Urol (2005) 0.75
National Institutes of Health Chronic Prostatitis Symptom Index for Japanese men. J Urol (2003) 0.75
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States. J Urol (2003) 0.75
Physical therapist management of fluoroquinolone-induced Achilles tendinopathy. J Urol (2003) 0.75
Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation. J Urol (2003) 0.75
Non-secretor status is associated with female acute uncomplicated pyelonephritis. J Urol (2003) 0.75
Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. J Urol (2003) 0.75